Philipp Lutz

8PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)GenomicsCardiology (incl. cardiovascular diseases)Bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study.

|Apr 26, 2025
Multiplex PCR for Microbiological Testing in Patients with Peritoneal Dialysis- and Liver Cirrhosis-Related Peritonitis: Faster, but Less Sensitive.

Sebastian Schwab, Daniel Pörner, Dominik Boes

|Apr 26, 2024
The challenge of replicating putative genetic risk factors in a population-based database.

H D Nischalke, F Schmalz, B Krämer

|Jul 19, 2023
Catecholamines and inflammation in advanced liver disease: more closely intertwined than expected?

Hans Dieter Nischalke, Christina Nischalke, Franziska Schmalz

|Jul 04, 2023
Rifaximin may induce rifampicin resistance in coagulase-negative staphylococci.

Lina M Schulte, Jacob Nattermann, Christian P Strassburg

|Nov 14, 2022
Persisting dental foci increase the risk for bacterial infections before and after liver transplant.

Philipp Göbel, Christiane Forsting, Alexandra Klüners

Pageof 2

Frequent Collaborators

3 joint publications

Christian Strassburg

1 joint publications

Jacob Nattermann

1 joint publications

Sebastian Schwab

1 joint publications

Achim Hoerauf